BiondVax Pharmaceuticals Ltd. (BVXV) distance from 20-day Simple moving Average is 38.71%: What to Expect?

Let’s start up with the current stock price of BiondVax Pharmaceuticals Ltd. (BVXV), which is $4.16 to be very precise. The Stock rose vividly during the last session to $4.61 after opening rate of $3.6935 while the lowest price it went was recorded $3.62 before closing at $3.63.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Recently in News on October 23, 2020, /C O R R E C T I O N — BiondVax Pharmaceuticals Ltd./. In the news release, BiondVax Announces Topline Results from Phase 3 Clinical Trial of the M-001 Universal Influenza Vaccine Candidate, issued Oct. 23, 2020 by BiondVax Pharmaceuticals Ltd. over PR Newswire, we are advised by the company that the Forward Looking Statements were not included. The complete, corrected release follows:. You can read further details here

A Backdoor Way To Profit From Today’s Crypto Bull Market

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .


BiondVax Pharmaceuticals Ltd. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $62.00 on 07/13/20, with the lowest value was $2.35 for the same time period, recorded on 11/09/20.

BiondVax Pharmaceuticals Ltd. (BVXV) full year performance was -27.90%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, BiondVax Pharmaceuticals Ltd. shares are logging -93.29% during the 52-week period from high price, and 77.02% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $2.35 and $62.00.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 3449662 for the day, which was evidently higher, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the BiondVax Pharmaceuticals Ltd. (BVXV) recorded performance in the market was -55.22%, having the revenues showcasing -89.52% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 40.89M, as it employees total of 17 workers.

BiondVax Pharmaceuticals Ltd. (BVXV) in the eye of market guru’s

During the last month, 0 analysts gave the BiondVax Pharmaceuticals Ltd. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on, the moving average of the company in the 100-day period was set at 27.68, with a change in the price was noted -38.84. In a similar fashion, BiondVax Pharmaceuticals Ltd. posted a movement of -90.33% for the period of last 100 days, recording 700,790 in trading volumes.

BiondVax Pharmaceuticals Ltd. (BVXV): Stocks Technical analysis and Trends

Raw Stochastic average of BiondVax Pharmaceuticals Ltd. in the period of last 50 days is set at 4.39%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 80.09%. In the last 20 days, the company’s Stochastic %K was 76.82% and its Stochastic %D was recorded 67.42%.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

If we look into the earlier routines of BiondVax Pharmaceuticals Ltd., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -55.22%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -77.39%, alongside a downfall of -27.90% for the period of the last 12 months. The shares increased approximately by 27.61% in the 7-day charts and went down by 51.27% in the period of the last 30 days. Common stock shares were lifted by -89.52% during last recorded quarter.

Get The Best Stocks To Trade Every Day!

Join now to get the pre-market morning brief 100% free


Please enter your comment!
Please enter your name here